Literature DB >> 2993515

Corticotropin-peptide regulation of intracellular cyclic AMP production in cortical neurons in primary culture.

S Weiss, M Sebben, J Bockaert.   

Abstract

Previous studies have provided evidence for adrenocorticotropic hormone (ACTH) effects on a wide variety of behaviors. However, the precise sites of action and the mechanisms by which these effects may be mediated have yet to be clearly elucidated. Although ACTH was shown to augment cyclic AMP levels in glial cells isolated from whole brain, other studies found little or no effect of ACTH peptides on cyclic nucleotide metabolism in slices of cerebral cortex or homogenates of whole brain. In the present study, our objective was to determine whether ACTH peptides regulate intracellular cyclic AMP levels in neurons of the cerebral cortex in primary culture. ACTH peptides stimulated cyclic AMP synthesis up to threefold in a dose-dependent manner; stimulation was complete within 5-10 min of exposure to agonists. Neurohormone efficacy was augmented by 0.1 microM forskolin (which was virtually ineffective alone); potency was unaffected. The order of potency (EC50) for increasing intracellular cyclic AMP levels was as follows: ACTH (1-24), ACTH (1-17) (10 nM) greater than alpha-melanocyte stimulating hormone, beta-melanocyte stimulating hormone (alpha-MSH, beta-MSH) (100 nM) greater than ACTH (1-10) (1 microM) greater than ACTH (4-10) (5 microM). The hexapeptide ACTH (4-9) as well as ACTH (11-24) were inactive at concentrations as high as 10 microM. Other neuropeptides derived from proopiocortin, such as beta-endorphin and Met- and Leu-enkephalin were without effect on basal or hormonally stimulated cyclic AMP synthesis.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2993515     DOI: 10.1111/j.1471-4159.1985.tb04074.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  8 in total

1.  L-365,260 inhibits in vitro acid secretion by interacting with a PKA pathway.

Authors:  C Oiry; J Pannequin; A Cormier; J C Galleyrand; J Martinez
Journal:  Br J Pharmacol       Date:  1999-05       Impact factor: 8.739

2.  Characterization of specific V1a vasopressin-binding sites on a rat mammary-tumour-cell line.

Authors:  G Guillon; C J Kirk; M N Balestre
Journal:  Biochem J       Date:  1986-11-15       Impact factor: 3.857

3.  Synaptogenesis of cultured striatal neurons in serum-free medium: a morphological and biochemical study.

Authors:  S Weiss; J P Pin; M Sebben; D E Kemp; F Sladeczek; J Gabrion; J Bockaert
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

4.  Cholera-toxin and corticotropin modulation of inositol phosphate accumulation induced by vasopressin and angiotensin II in rat glomerulosa cells.

Authors:  G Guillon; N Gallo-Payet; M N Balestre; C Lombard
Journal:  Biochem J       Date:  1988-08-01       Impact factor: 3.857

5.  Adenosine induces cyclic-AMP formation and inhibits endothelin-1 production/secretion in guinea-pig tracheal epithelial cells through A(2B) adenosine receptors.

Authors:  S Pelletier; J Dubé; A Villeneuve; F Gobeil; S G Bernier; B Battistini; G Guillemette; P Sirois
Journal:  Br J Pharmacol       Date:  2000-01       Impact factor: 8.739

6.  Influence of bacterial toxins and forskolin upon vasopressin-induced inositol phosphate accumulation in WRK 1 cells.

Authors:  G Guillon; M N Balestre; C Lombard; F Rassendren; C J Kirk
Journal:  Biochem J       Date:  1989-06-15       Impact factor: 3.857

7.  Inhibition of basal and stimulated release of endothelin-1 from guinea pig tracheal epithelial cells in culture by beta 2-adrenoceptor agonists and cyclic AMP enhancers.

Authors:  Quan Yang; Bruno Battistini; Stéphane Pelletier; Pierre Sirois
Journal:  Inflammation       Date:  2007-10       Impact factor: 4.092

8.  Guinea pig medial vestibular nucleus neurons in vitro respond to ACTH4-10 at picomolar concentrations.

Authors:  C L Darlington; P F Smith; J I Hubbard
Journal:  Exp Brain Res       Date:  1990       Impact factor: 1.972

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.